Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Marc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, Frederico LA Fernandes, Jorge Dreyse, José R Jardim, Siwasak Juthong, Gur Levy & Martin Sivori. (2023) Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1853-1866.
Read now
Read now
Thitiwat Sriprasart, Ma Bella Siasoco, Bhumika Aggarwal, Gur Levy, Abhay Phansalkar, Giap Vu Van, Mark Cohen, Terence Seemungal, Marcia M. M. Pizzichini, Mahmoud Mokhtar & Peter Daley-Yates. (2023) The role of modeling studies in asthma management and clinical decision-making: a Delphi survey of physician knowledge and perceptions. Journal of Asthma 60:9, pages 1687-1701.
Read now
Read now
Christian Domingo, Gabriel Garcia, Bilun Gemicioglu, Giap Vu Van, Désirée Larenas-Linnemann, Hugo Neffen, Orapan Poachanukoon, Hironori Sagara, Norbert Berend, Emilio Pizzichini, Elvis Irusen, Bhumika Aggarwal, Volkan Eken & Gur Levy. (2023) Consensus on mild asthma management: results of a modified Delphi study. Journal of Asthma 60:1, pages 145-157.
Read now
Read now
David Price & Elizabeth V Hillyer. (2014) Fluticasone propionate/formoterol fumarate in fixed-dose combination for the treatment of asthma. Expert Review of Respiratory Medicine 8:3, pages 275-291.
Read now
Read now
Anna Bodzenta-Lukaszyk, Jan van Noord, Winfried Schröder-Babo, Kirsten McAulay & Tammy McIver. (2013) Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial. Current Medical Research and Opinion 29:5, pages 579-588.
Read now
Read now
Richard D O’Connor. (2011) Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes. Patient Related Outcome Measures 2, pages 41-55.
Read now
Read now
William E. Berger & Michael J. Noonan. (2010) Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler. Journal of Asthma 47:4, pages 447-459.
Read now
Read now
Kevin R Murphy & Bruce G Bender. (2009) Treatment of moderate to severe asthma: patient perspectives on combination inhaler therapy and implications for adherence. Journal of Asthma and Allergy 2, pages 63-72.
Read now
Read now
Articles from other publishers (12)
Emily J. Henderson, Gemma S. Morgan, Jigisha Amin, Daisy M. Gaunt & Yoav Ben-Shlomo. (2019) The minimum clinically important difference (MCID) for a falls intervention in Parkinson's: A delphi study. Parkinsonism & Related Disorders 61, pages 106-110.
Crossref
Crossref
Adel H. MansurKirsten Kaiser. (2013) Long-Term Safety and Efficacy of Fluticasone/Formoterol Combination Therapy in Asthma. Journal of Aerosol Medicine and Pulmonary Drug Delivery 26:4, pages 190-199.
Crossref
Crossref
Kate McKeage. (2013) Fluticasone Propionate/Formoterol Fumarate: A Review of Its Use in Persistent Asthma. Drugs 73:2, pages 195-206.
Crossref
Crossref
David Price & Jean Bousquet. (2012) Real-world perceptions of inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma. Respiratory Medicine 106, pages S4-S8.
Crossref
Crossref
Alberto Papi. (2012) A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice?. Respiratory Medicine 106, pages S1-S3.
Crossref
Crossref
René Aalbers, Guy Brusselle, Tammy McIver, Birgit Grothe & Anna Bodzenta-Lukaszyk. (2012) Onset of Bronchodilation with Fluticasone/Formoterol Combination Versus Fluticasone/Salmeterol in an Open-Label, Randomized Study. Advances in Therapy 29:11, pages 958-969.
Crossref
Crossref
Randall W. Brown, Christopher D. O'Brien, Ubaldo J. Martin, Tom Uryniak & Kathy L. Lampl. (2012) Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial. Journal of Allergy and Clinical Immunology 130:2, pages 362-367.e9.
Crossref
Crossref
Jeremy J. Wildfire, Peter J. Gergen, Christine A. Sorkness, Herman E. Mitchell, Agustin Calatroni, Meyer Kattan, Stanley J. Szefler, Stephen J. Teach, Gordon R. Bloomberg, Robert A. Wood, Andrew H. Liu, Jacqueline A. Pongracic, James F. Chmiel, Kathleen Conroy, Yadira Rivera-Sanchez, William W. Busse & Wayne J. Morgan. (2012) Development and validation of the Composite Asthma Severity Index—an outcome measure for use in children and adolescents. Journal of Allergy and Clinical Immunology 129:3, pages 694-701.
Crossref
Crossref
Omar S. Usmani. (2012) Treating the Small Airways. Respiration 84:6, pages 441-453.
Crossref
Crossref
Jean Bousquet, Chris Winchester, Alberto Papi, J. Christian Virchow, John Haughney, David Costa, Omar Usmani, Leif Bjermer & David Price. (2012) Inhaled Corticosteroid/Long-Acting β2-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe. International Archives of Allergy and Immunology 157:3, pages 303-310.
Crossref
Crossref
Anna Bodzenta-Lukaszyk, Andrzej Dymek, Kirsten McAulay & Heikki Mansikka. (2011) Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
Richard J. Swartz, Carolyn Schwartz, Ethan Basch, Li Cai, Diane L. Fairclough, Lori McLeod, Tito R. Mendoza & Bruce Rapkin. (2011) The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of change. Quality of Life Research 20:8, pages 1159-1167.
Crossref
Crossref